Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?
Nardelli C, Gentile I, Setaro M, Di Domenico C, Pinchera B, Buonomo AR, Zappulo E, Scotto R, Scaglione GL, Castaldo G, Capoluongo E. Nardelli C, et al. Among authors: capoluongo e. Front Cell Infect Microbiol. 2021 Feb 15;11:625581. doi: 10.3389/fcimb.2021.625581. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33659220 Free PMC article.
Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie.
De Angelis C, Nardelli C, Concolino P, Pagliuca M, Setaro M, De Paolis E, De Placido P, Forestieri V, Scaglione GL, Ranieri A, Lombardo B, Pastore L, De Placido S, Capoluongo E. De Angelis C, et al. Among authors: capoluongo e. Front Oncol. 2021 Feb 24;11:602523. doi: 10.3389/fonc.2021.602523. eCollection 2021. Front Oncol. 2021. PMID: 33718150 Free PMC article.
Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation.
Ferrucci V, de Antonellis P, Quarantelli F, Asadzadeh F, Bibbò F, Siciliano R, Sorice C, Pisano I, Izzo B, Di Domenico C, Boccia A, Vargas M, Pierri B, Viscardi M, Brandi S, Fusco G, Cerino P, De Pietro L, Furfaro C, Napolitano LA, Paolella G, Festa L, Marzinotto S, Conte MC, Gentile I, Servillo G, Curcio F, de Cristofaro T, Broccolo F, Capoluongo E, Zollo M. Ferrucci V, et al. Among authors: capoluongo e. Int J Mol Sci. 2022 Feb 9;23(4):1941. doi: 10.3390/ijms23041941. Int J Mol Sci. 2022. PMID: 35216056 Free PMC article.
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.
Capoluongo ED, Pellegrino B, Arenare L, Califano D, Scambia G, Beltrame L, Serra V, Scaglione GL, Spina A, Cecere SC, De Cecio R, Normanno N, Colombo N, Lorusso D, Russo D, Nardelli C, D'Incalci M, Llop-Guevara A, Pisano C, Baldassarre G, Mezzanzanica D, Artioli G, Setaro M, Tasca G, Roma C, Campanini N, Cinieri S, Sergi A, Musolino A, Perrone F, Chiodini P, Marchini S, Pignata S. Capoluongo ED, et al. ESMO Open. 2022 Oct;7(5):100585. doi: 10.1016/j.esmoop.2022.100585. Epub 2022 Sep 23. ESMO Open. 2022. PMID: 36156447 Free PMC article. Clinical Trial.
A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations.
Concolino P, Costella A, Minucci A, Scaglione GL, Santonocito C, Salutari V, Scambia G, Zuppi C, Capoluongo E. Concolino P, et al. Among authors: capoluongo e. Clin Chim Acta. 2014 Nov 1;437:72-7. doi: 10.1016/j.cca.2014.06.026. Epub 2014 Jul 5. Clin Chim Acta. 2014. PMID: 25007954
290 results